Trial Profile

A study of COR-003 in healthy volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 17 May 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Levoketoconazole (Primary) ; Atorvastatin; Ketoconazole
Indications Cushing syndrome
Focus Adverse reactions; Pharmacokinetics

Most Recent Events

10 May 2018 According to a Strongbridge Biopharma media release,Presented results from an in vitro study of levoketoconazole, the active ingredient in RECORLEV, at ENDO 2018, the Annual Meeting of the Endocrine Society
06 Apr 2016 New trial record
04 Apr 2016 According to a Strongbridge Biopharma media release, results from this study were presented at the Endocrine Society's 2016 Annual Meeting and Expo.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com